Breast MRI for cancer detection and characterization: a review of evidence-based clinical applications.

RATIONALE AND OBJECTIVES Breast MRI is an important new tool in the imaging armamentarium for the detection and characterization of breast carcinoma. Understanding the evidence-supported benefits and potential harms of breast MRI is important to ensure the appropriate utilization of this medical resource. MATERIALS AND METHODS This article reviews the clinical settings in which MRI for breast cancer assessment has been shown to be advantageous. The evidence regarding the diagnostic accuracy of MRI and the impact of this imaging tool on clinical outcomes are described. Novel breast MRI techniques which may lead to future improvements in performance are discussed. RESULTS Breast MRI has been shown in multiple studies to be advantageous for screening patients at high risk, evaluating patients with a new breast cancer diagnosis, monitoring treatment response in patients undergoing neoadjuvant chemotherapy and evaluating patients with metastatic axillary adenocarcinoma and unknown primary site. Among the limitations of MRI are its high cost and modest specificity resulting in false positive examinations. CONCLUSIONS When used in evidence-supported clinical settings, the high sensitivity of MRI results in earlier cancer detection or greater accuracy of detection compared to existing tests for breast carcinoma. Further scientific endeavors are crucial to optimize the future performance and application of breast MRI.

[1]  Constantine Gatsonis,et al.  Screening women at high risk for breast cancer with mammography and magnetic resonance imaging , 2005, Cancer.

[2]  M D Schnall,et al.  Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. , 1995, Radiology.

[3]  Petrina Causer,et al.  MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883 , 2005, Journal of surgical oncology.

[4]  A. D. De Schepper,et al.  Contrast-enhanced MR imaging of breast lesions and effect on treatment. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[5]  C. Balu-Maestro,et al.  Imaging in Evaluation of Response to Neoadjuvant Breast Cancer Treatment Benefits of MRI , 2002, Breast Cancer Research and Treatment.

[6]  Ellen Warner,et al.  Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination , 2004, JAMA.

[7]  Elizabeth A Morris,et al.  MRI of occult breast carcinoma in a high-risk population. , 2003, AJR. American journal of roentgenology.

[8]  E. Copeland,et al.  Book Review The Breast: Comprehensive management of benign and malignant diseases Second edition. Edited by Kirby I. Bland and Edward M. Copeland III. 1631 pp. in two volumes, illustrated. Philadelphia, W.B. Saunders, 1998. $225. 0-7216-6656-6 , 1999 .

[9]  L. Esserman,et al.  Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  M. Dewhirst,et al.  Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. , 2003, AJR. American journal of roentgenology.

[11]  Ning-Yu An,et al.  Differentiation of clinically benign and malignant breast lesions using diffusion‐weighted imaging , 2002, Journal of magnetic resonance imaging : JMRI.

[12]  J. Olson,et al.  Magnetic Resonance Imaging Facilitates Breast Conservation for Occult Breast Cancer , 2000, Annals of Surgical Oncology.

[13]  Daniele Regge,et al.  Monitoring Response to Primary Chemotherapy in Breast Cancer using Dynamic Contrast-enhanced Magnetic Resonance Imaging , 2004, Breast Cancer Research and Treatment.

[14]  E. Morris,et al.  Utility of Breast Magnetic Resonance Imaging in Patients With Occult Primary Breast Cancer , 2005, Annals of Surgical Oncology.

[15]  N. Hylton,et al.  Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: Results from the International Breast Magnetic Resonance Consortium (IBMC) trial , 2005, Journal of surgical oncology.

[16]  S. Harms,et al.  Role of breast magnetic resonance imaging in determining breast as a source of unknown metastatic lymphadenopathy. , 1999, American journal of surgery.

[17]  Laura Cortesi,et al.  Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. , 2007, Radiology.

[18]  C. Zuiani,et al.  The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. , 2002, Journal of experimental & clinical cancer research : CR.

[19]  Anna L. Brown,et al.  Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  D. Fraker,et al.  Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. , 1999, Radiology.

[21]  M Oudkerk,et al.  MR imaging-guided sonography followed by fine-needle aspiration cytology in occult carcinoma of the breast. , 2000, AJR. American journal of roentgenology.

[22]  Ying Lu,et al.  Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. , 2002, AJR. American journal of roentgenology.

[23]  S E Harms,et al.  Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging , 1996, Cancer.

[24]  Usha Sinha,et al.  In vivo diffusion‐weighted MRI of the breast: Potential for lesion characterization , 2002, Journal of magnetic resonance imaging : JMRI.

[25]  Matthijs Oudkerk,et al.  First experiences in screening women at high risk for breast cancer with MR imaging , 2000, Breast Cancer Research and Treatment.

[26]  Hans H Schild,et al.  Effect of B1 inhomogeneity on breast MR imaging at 3.0 T. , 2007, Radiology.

[27]  D. Schultz,et al.  Role of magnetic resonance imaging and magnetic resonance imaging--guided surgery in the evaluation of patients with early-stage breast cancer for breast conservation treatment. , 1999, American journal of clinical oncology.

[28]  Mitchell D Schnall,et al.  MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. , 2003, Radiology.

[29]  Ying Lu,et al.  MRI Phenotype Is Associated With Response to Doxorubicin and Cyclophosphamide Neoadjuvant Chemotherapy in Stage III Breast Cancer , 2001, Annals of Surgical Oncology.

[30]  S E Harms,et al.  MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. , 1993, Radiology.

[31]  D. Schultz,et al.  Effect of breast magnetic resonance imaging on the clinical management of women with early-stage breast carcinoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  E. Merkle,et al.  MRI of histologically confirmed mammary carcinoma: clinical relevance of diagnostic procedures for detection of multifocal or contralateral secondary carcinoma. , 1997, Journal of computer assisted tomography.

[33]  Rebecca S Lewis,et al.  Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. , 2004, Radiology.

[34]  C. Gatsonis,et al.  Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. , 2007, Radiology.

[35]  Jennifer B Kaplan,et al.  MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. , 2003, AJR. American journal of roentgenology.

[36]  H Mumtaz,et al.  Staging of symptomatic primary breast cancer with MR imaging. , 1997, AJR. American journal of roentgenology.

[37]  Jürgen Gieseke,et al.  Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience. , 2006, Radiology.

[38]  Carmel Hayes,et al.  Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results. , 2006, Radiology.

[39]  Masanori Ozaki,et al.  ADC mapping of benign and malignant breast tumors. , 2005, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[40]  Uwe Fischer,et al.  The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer , 2004, European Radiology.

[41]  Michael Laniado,et al.  MR imaging of the contralateral breast in patients after breast-conserving therapy , 2004, European Radiology.

[42]  K. Brandt,et al.  Adding in vivo quantitative 1H MR spectroscopy to improve diagnostic accuracy of breast MR imaging: preliminary results of observer performance study at 4.0 T. , 2005, Radiology.

[43]  Elizabeth A Morris,et al.  MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. , 2003, AJR. American journal of roentgenology.

[44]  J. M. Taylor,et al.  Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. , 2000, Journal of the National Cancer Institute.

[45]  E Grabbe,et al.  Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. , 1999, Radiology.

[46]  Min-Ying Su,et al.  Monitoring the Size and Response of Locally Advanced Breast Cancers to Neoadjuvant Chemotherapy (Weekly Paclitaxel and Epirubicin) with Serial Enhanced MRI , 2003, Breast Cancer Research and Treatment.

[47]  I. Zuna,et al.  Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution , 2002, European Radiology.

[48]  M. Yaffe,et al.  American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007 .

[49]  R. Fimmers,et al.  Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[50]  Thierry Metens,et al.  Quantitative diffusion imaging in breast cancer: A clinical prospective study , 2006, Journal of magnetic resonance imaging : JMRI.

[51]  J. Bryant,et al.  Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. , 2001, Journal of the National Cancer Institute. Monographs.

[52]  L. Turnbull,et al.  Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy , 2005, Breast Cancer Research and Treatment.

[53]  D. Yee,et al.  Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy--a pilot study at 4 T. , 2004, Radiology.

[54]  H Zeitler,et al.  MRI of breast cancer: influence of chemotherapy on sensitivity. , 1997, The British journal of radiology.

[55]  R. Ponzone,et al.  Role of Magnetic Resonance Imaging in the prediction of tumor response in patients with locally advanced breast cancer receiving neoadjuvant chemo-therapy. , 2003, La Radiologia medica.

[56]  Peter Gibbs,et al.  Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. , 2006, Magnetic resonance imaging.

[57]  N. Hylton,et al.  Magnetic resonance imaging of the breast prior to biopsy. , 2004, JAMA.

[58]  Isabelle Bedrosian,et al.  Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging , 2003, Cancer.

[59]  S. Edge,et al.  Breast MRI in the Evaluation of Patients with Occult Primary Breast Carcinoma , 1999, The breast journal.

[60]  A R Padhani,et al.  Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) , 2005, The Lancet.

[61]  C. Gatsonis,et al.  MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. , 2007, The New England journal of medicine.

[62]  D. Kopans,et al.  Occult Contralateral Breast Carcinoma Incidentally Detected by Breast Magnetic Resonance Imaging , 2002, The breast journal.

[63]  C. Catalano,et al.  Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions. , 2007, Radiology.

[64]  L. Turnbull,et al.  Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy , 2006, British Journal of Cancer.

[65]  R. Gillies,et al.  Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. , 2004, Neoplasia.

[66]  D. Mankoff,et al.  Combined use of MRI and PET to monitor response and assess residual disease for locally advanced breast cancer treated with neoadjuvant chemotherapy. , 2004, Academic radiology.

[67]  R. Ordidge,et al.  Carcinoma of the breast imaged by nuclear magnetic resonance (NMR). , 1979, The British journal of radiology.

[68]  Constance D. Lehman,et al.  Computer-Aided Detection Applied to Breast MRI: Assessment of CAD-Generated Enhancement and Tumor Sizes in Breast Cancers Before and After Neoadjuvant Chemotherapy1 , 2005 .

[69]  Y. Ogawa,et al.  Utility of initial MRI for predicting extent of residual disease after neoadjuvant chemotherapy: analysis of 70 breast cancer patients. , 2004, Oncology reports.

[70]  G J Metzger,et al.  MRI vs. histologic measurement of breast cancer following chemotherapy: Comparison with x‐ray mammography and palpation , 2001, Journal of magnetic resonance imaging : JMRI.

[71]  H. D. de Koning,et al.  Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. , 2004, The New England journal of medicine.